Clinical Trial Update: Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial in chronic hepatitis C evaluated antiviral pharmacodynamics, safety, and pharmacokinetics of escalating doses of BILB 1941 ZW; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BILB 1941 ZW

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatitis C, Chronic | Phase 1, Phase 2 | Status: COMPLETED